Mayne Pharma Group Ltd MAYNF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.05
- Day Range
- $1.87–1.97
- 52-Week Range
- $1.40–4.00
- Bid/Ask
- $1.80 / $2.15
- Shares Outstanding
- 81.89M
- Market Cap
- $151.93M
- Volume/Avg
- 8,135 / 5,893
Key Statistics
- Price/Earnings (Normalized)
- 14.74
- Price/Sales
- 0.59
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Mayne Pharma Group Ltd is a specialty pharmaceutical company focused on commercialising branded women's health and dermatology pharmaceuticals, offering patients better, safer, and more accessible medicines. The Company has a product development and manufacturing facility in Salisbury, Australia, with expertise in the formulation of complex oral and topical dose forms, including modified-release products and poorly soluble compounds. Its segments are Women's Health, Dermatology and International. The Women's Health segment generates maximum revenue and distributes branded products in the US, including NEXTSTELLIS, ANNOVERA, IMVEXXY, and BIJUVA. The Company generates maximum revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Value
- Total Number of Employees
- 160
- Website
- https://www.maynepharma.com
Valuation
|
Metric
|
MAYNF
|
|---|---|
Price/Earnings (Normalized) | 14.74 |
Price/Book Value | 0.56 |
Price/Sales | 0.59 |
Price/Cash Flow | 18.78 |
Price/Earnings
MAYNF
Financial Strength
|
Metric
|
MAYNF
|
|---|---|
Quick Ratio | 0.98 |
Current Ratio | 1.31 |
Interest Coverage | 1.81 |
Quick Ratio
MAYNF
Profitability
|
Metric
|
MAYNF
|
|---|---|
Return on Assets (Normalized) | 4.10% |
Return on Equity (Normalized) | 10.54% |
Return on Invested Capital (Normalized) | 17.03% |
Return on Assets
MAYNF
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|%>#yZ$ | LOCK|^$zq | $109B | |||
| Cencora Inc
COR
| LOCK|mSTFJ^y | LOCK|?QWz | $62B | |||
| Cardinal Health Inc
CAH
| LOCK|#wl&r#> | LOCK|YLZX$ | $55B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|H%&&< | $22B | |||
| Henry Schein Inc
HSIC
| LOCK|?>ZZN&m | LOCK|zjTv | $9B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|<$ | $8B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|B$ | $6B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|$Ky | $6B | |||
| Galenica Ltd
GALNF
| — | LOCK|k$%$Q | $5B | |||
| Medipal Holdings Corp
MEPDF
| — | LOCK|$p> | $4B |
United States